DaVita Inc. filed an 8-K on November 3, 2026, announcing that Chief Financial Officer Joel Ackerman and Group Vice President of Investor Relations Nic Eliason will participate in fireside chats at two upcoming investor conferences on November 9 and November 10, 2026.

Key Highlights

  • Participants: CFO Joel Ackerman and Group VP of Investor Relations Nic Eliason will represent DaVita at both events.
  • UBS Global Healthcare Conference 2026: Fireside chat scheduled for Monday, November 9, 2026, at 1:15 pm EST.
  • Wolfe Research Healthcare Conference 2026: Fireside chat scheduled for Tuesday, November 10, 2026, at 8:40 am EST.
  • Webcasts: Both presentations are available via live webcast through the respective conference pages with free registration.
  • Patient scale: As of September 30, 2026, DaVita reported serving approximately 298,100 patients at 3,269 outpatient dialysis centers globally, according to the filing.

DaVita Executives Scheduled for Back-to-Back Healthcare Conference Appearances

According to the filing, DaVita Inc. (NYSE:DVA) announced on November 3, 2026, that two senior executives will appear at a pair of investor conferences within consecutive days. CFO Joel Ackerman and Group Vice President of Investor Relations Nic Eliason are named as the company's representatives at both events.

The first appearance is a fireside chat at the UBS Global Healthcare Conference 2026, set for Monday, November 9, 2026, at 1:15 pm EST. The second is at the Wolfe Research Healthcare Conference 2026 on Tuesday, November 10, 2026, at 8:40 am EST. The filing states that live webcasts for both sessions are accessible through the respective conference pages, each requiring a free registration.

The filing also includes background on DaVita's operations. As of September 30, 2026, the company reported providing dialysis services to approximately 298,100 patients at 3,269 outpatient dialysis centers. Of those, 2,671 centers were located in the United States and 598 centers were located in 14 countries outside of the United States, according to the disclosure.

What Was Disclosed

DaVita disclosed the participation of CFO Joel Ackerman and Group VP of Investor Relations Nic Eliason in fireside chats at the UBS Global Healthcare Conference on November 9, 2026, and the Wolfe Research Healthcare Conference on November 10, 2026, with live webcasts available for both.